XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Segments (Tables)
 6 Months Ended
Jun. 30, 2022
Segment Reporting [Abstract]  
Operations and Assets for Operating Segments and Geographic Information Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 For the three months ended June 30,For the six months ended June 30,
(In thousands)2022202120222021
Revenue from services:
Pharmaceutical$— $— $— $— 
Diagnostics186,804 397,197 473,402 904,149 
Corporate— — — — 
$186,804 $397,197 $473,402 $904,149 
Revenue from products:
Pharmaceutical$35,892 $35,663 $72,550 $69,608 
Diagnostics— — — — 
Corporate— — — — 
$35,892 $35,663 $72,550 $69,608 
Revenue from transfer of intellectual property and other:
Pharmaceutical$87,197 $9,548 $93,159 $13,816 
Diagnostics— — — — 
Corporate— — — — 
$87,197 $9,548 $93,159 $13,816 
Operating income (loss):
Pharmaceutical$55,435 $(13,710)$37,327 $(32,868)
Diagnostics(57,543)30,000 (101,092)97,014 
Corporate(8,631)(10,719)(19,399)(20,138)
$(10,739)$5,571 $(83,164)$44,008 
Depreciation and amortization:
Pharmaceutical$17,840 $7,007 $33,242 $14,420 
Diagnostics10,155 13,566 22,567 26,141 
Corporate— — — — 
$27,995 $20,573 $55,809 $40,561 
Loss from investment in investees:
Pharmaceutical$(268)$(67)$(316)$(110)
Diagnostics— — — — 
Corporate— — — — 
$(268)$(67)$(316)$(110)
Revenues:
United States$193,105 $402,291 $484,913 $915,163 
Ireland89,177 12,088 97,638 19,218 
Chile15,804 18,657 32,143 32,809 
Spain5,696 5,437 12,805 11,356 
Israel1,854 724 3,412 3,235 
Mexico4,055 3,039 7,805 5,457 
Other202 172 395 335 
$309,893 $442,408 $639,111 $987,573 
(In thousands)June 30,
2022		December 31,
2021
Assets:
Pharmaceutical$1,354,058 $1,114,460 
Diagnostics748,165 1,238,583 
Corporate267,379 46,672 
$2,369,602 $2,399,715 
Goodwill:
Pharmaceutical$295,820 $237,576 
Diagnostics283,025 283,025 
$578,845 $520,601